The oncologist
Correction to: Long-term safety of selpercatinib for Rearranged during transfection (RET)-activated advanced solid tumors in LIBRETTO-001: differing patterns of adverse events over time.
Published: 202510.1093/oncolo/oyaf068
No abstract available for this study.